CNE000001840
CNE000001840
TIANJIN TIANYAO PHARMACEUTICAL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 7.06B EUR | 5.72B EUR | 4.47B EUR |
Enterprise Value | 7.7B EUR | 5.7B EUR | 4.38B EUR |
Valuation Multiples | |||
Trailing P/E | 107.83x | 927.31x | 88.73x |
Forward P/E | -- | -- | -- |
Price to Sales | 2.68x | 2.74x | 1.97x |
Price to Book | 2.34x | 1.88x | 1.47x |
EV/Revenue | 2.93x | 2.73x | 1.93x |
EV/EBITDA | 19.43x | 37.35x | 21.37x |
Price to FCF (P/FCF) | 28.24x | 64.62x | 52.62x |
EV/FCF | 30.8x | 64.43x | 51.58x |
FCF Yield | 3.54% | 1.55% | 1.9% |